Semavi 0.25mg Injection contains Semaglutide, a GLP-1 receptor agonist used to manage type 2 diabetes and support weight reduction. It works by improving insulin secretion, lowering blood sugar levels, slowing gastric emptying, and reducing appetite. Regular use helps achieve better glycemic control and supports gradual, sustained weight loss when combined with diet and exercise. This injection is usually started at a low dose to improve tolerance and minimize side effects.

Uses

• Treats type 2 diabetes mellitus

• Helps control blood sugar levels

• Supports weight management

• Reduces appetite and food intake

• Improves insulin response

Benefits

• Provides effective glycemic control

• Supports gradual and sustainable weight loss

• Lowers risk of diabetes-related complications

• Improves metabolic health

• Convenient once-weekly dosing

Dosage

• Take as directed by your doctor

• Typically 0.25mg once weekly (starting dose)

• Inject subcutaneously in abdomen, thigh, or upper arm

• Same day each week

• Do not exceed recommended dose

Side Effects

• Nausea or vomiting

• Diarrhea or constipation

• Decreased appetite

• Rare injection site reactions

FAQs

Q1: Who should use Semavi 0.25mg Injection?

Adults with type 2 diabetes or obesity, as prescribed by a doctor.

Q2: Is 0.25mg a full treatment dose?

No — it is a starting dose to help the body adjust before dose escalation.

Q3: How long does it take to work?

Blood sugar improvement may begin within the first few weeks.

Q4: Can it be used for weight loss?

Yes — under medical supervision, it supports appetite control and weight reduction.

Q5: Can it be used with insulin?

Yes — but only under medical guidance.

Q6: Is it safe for long-term use?

Yes — when monitored by a healthcare professional.

Q7: How should it be stored?

Store refrigerated between 2°C–8°C.